United Therapeutics Corporation v. Liquidia Technologies, Inc.

Procedural entryThis page is a short order in United Therapeutics Corporation v. Liquidia Technologies, Inc.. Read the opinion of the Court — 74 F.4th 1360
Court of Appeals for the Federal Circuit·Decided October 10, 2024·No. 24-1658·Unpublished

Opinion

Case: 24-1658 Document: 53 Page: 1 Filed: 10/10/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

UNITED THERAPEUTICS CORPORATION, Plaintiff-Appellant

v.

LIQUIDIA TECHNOLOGIES, INC., Defendant-Appellee ______________________

2024-1658 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00755-RGA, Judge Richard G. Andrews. ______________________

ON MOTION ______________________

Before PROST, HUGHES, and CUNNINGHAM, Circuit Judges. PER CURIAM. ORDER United Therapeutics Corporation moves to dismiss the above-captioned appeal pursuant to Fed. R. App. P. 42(b) with each side to bear its own costs. Upon consideration thereof, Case: 24-1658 Document: 53 Page: 2 Filed: 10/10/2024

IT IS ORDERED THAT: The motion is granted.

FOR THE COURT

October 10, 2024 Date

ISSUED AS A MANDATE: October 10, 2024

Free access — add to your briefcase to read the full text and ask questions with AI

United Therapeutics Corporation v. Liquidia Technologies, Inc., (Fed. Cir. 2024).

United Therapeutics Corporation v. Liquidia Technologies, Inc. (United Therapeutics Corporation v. Liquidia Technologies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.